HCA Healthcare (HCA) to Release Quarterly Earnings on Friday

HCA Healthcare (NYSE:HCA) will likely be releasing its earnings data before the market opens on Friday, January 24th. Analysts expect HCA Healthcare to post earnings of $6.03 per share and revenue of $18,234,322.79 billion for the quarter. Parties that are interested in registering for the company’s conference call can do so using this link.

HCA Healthcare Trading Up 0.3 %

Shares of NYSE:HCA opened at $319.53 on Thursday. HCA Healthcare has a one year low of $278.68 and a one year high of $417.14. The stock has a market capitalization of $80.94 billion, a PE ratio of 14.35, a price-to-earnings-growth ratio of 1.06 and a beta of 1.64. The company has a debt-to-equity ratio of 48.71, a current ratio of 1.12 and a quick ratio of 1.00. The company’s 50-day moving average price is $315.10 and its two-hundred day moving average price is $353.07.

HCA Healthcare Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Friday, December 27th. Investors of record on Friday, December 13th were issued a dividend of $0.66 per share. The ex-dividend date of this dividend was Friday, December 13th. This represents a $2.64 dividend on an annualized basis and a yield of 0.83%. HCA Healthcare’s payout ratio is 11.85%.

Wall Street Analysts Forecast Growth

Several equities research analysts have issued reports on the stock. Wells Fargo & Company downgraded shares of HCA Healthcare from an “equal weight” rating to an “underweight” rating and cut their price objective for the stock from $400.00 to $320.00 in a research report on Monday, November 25th. Cantor Fitzgerald reiterated an “overweight” rating and issued a $392.00 target price on shares of HCA Healthcare in a research report on Tuesday, October 1st. StockNews.com downgraded shares of HCA Healthcare from a “strong-buy” rating to a “buy” rating in a research report on Monday, November 4th. Truist Financial decreased their target price on shares of HCA Healthcare from $430.00 to $390.00 and set a “buy” rating for the company in a research report on Monday, January 6th. Finally, Raymond James lowered shares of HCA Healthcare from an “outperform” rating to a “market perform” rating in a research note on Friday, November 22nd. One investment analyst has rated the stock with a sell rating, three have issued a hold rating, twelve have assigned a buy rating and two have assigned a strong buy rating to the company. Based on data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $385.27.

Insider Activity

In related news, SVP Phillip G. Billington sold 3,897 shares of the company’s stock in a transaction dated Thursday, November 14th. The shares were sold at an average price of $350.00, for a total value of $1,363,950.00. Following the completion of the sale, the senior vice president now directly owns 52,702 shares of the company’s stock, valued at $18,445,700. This represents a 6.89 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, insider Erol R. Akdamar sold 2,900 shares of the company’s stock in a transaction that occurred on Thursday, November 14th. The stock was sold at an average price of $353.00, for a total transaction of $1,023,700.00. Following the completion of the sale, the insider now directly owns 6,843 shares of the company’s stock, valued at $2,415,579. The trade was a 29.76 % decrease in their position. The disclosure for this sale can be found here. Corporate insiders own 1.70% of the company’s stock.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.